644 related articles for article (PubMed ID: 33148325)
1. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
[TBL] [Abstract][Full Text] [Related]
2. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
4. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
[TBL] [Abstract][Full Text] [Related]
5. Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Herrera S; de Vega WC; Ashbrook D; Vernon SD; McGowan PO
Epigenetics; 2018; 13(12):1174-1190. PubMed ID: 30516085
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Helliwell AM; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233152
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation modifications associated with chronic fatigue syndrome.
de Vega WC; Vernon SD; McGowan PO
PLoS One; 2014; 9(8):e104757. PubMed ID: 25111603
[TBL] [Abstract][Full Text] [Related]
8. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [Abstract][Full Text] [Related]
9. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Johnston S; Staines D; Klein A; Marshall-Gradisnik S
BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.
Almenar-Pérez E; Ovejero T; Sánchez-Fito T; Espejo JA; Nathanson L; Oltra E
Clin Ther; 2019 Apr; 41(4):675-698. PubMed ID: 30910331
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
[TBL] [Abstract][Full Text] [Related]
12. Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome.
de Vega WC; Erdman L; Vernon SD; Goldenberg A; McGowan PO
Epigenomics; 2018 May; 10(5):539-557. PubMed ID: 29692205
[TBL] [Abstract][Full Text] [Related]
13. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
[TBL] [Abstract][Full Text] [Related]
14. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
15. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
[TBL] [Abstract][Full Text] [Related]
16. Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project.
Gamer J; Van Booven DJ; Zarnowski O; Arango S; Elias M; Kurian A; Joseph A; Perez M; Collado F; Klimas N; Oltra E; Nathanson L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373402
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
18. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.
Blauensteiner J; Bertinat R; León LE; Riederer M; Sepúlveda N; Westermeier F
Sci Rep; 2021 May; 11(1):10604. PubMed ID: 34011981
[TBL] [Abstract][Full Text] [Related]
19. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
20. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
Front Immunol; 2021; 12():687806. PubMed ID: 34326841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
